NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
39 hedge funds and large institutions have $2.15M invested in Nymox Pharmaceutical Corp in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Holders
39
Holding in Top 10
–
Calls
$35K
Puts
$37K
Top Buyers
| 1 | +$137K | |
| 2 | +$96K | |
| 3 | +$94K | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$58K |
| 5 |
WP
WMS Partners
Towson,
Maryland
|
+$53K |
Top Sellers
| 1 | -$132K | |
| 2 | -$44.1K | |
| 3 | -$33K | |
| 4 |
Millennium Management
New York
|
-$28K |
| 5 |
FTDI
First Trust Direct Indexing
Boston,
Massachusetts
|
-$15K |